BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33760360)

  • 1. A machine learning-based survival prediction model of high grade glioma by integration of clinical and dose-volume histogram parameters.
    Chen H; Li C; Zheng L; Lu W; Li Y; Wei Q
    Cancer Med; 2021 Apr; 10(8):2774-2786. PubMed ID: 33760360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comparison Study of Machine Learning (Random Survival Forest) and Classic Statistic (Cox Proportional Hazards) for Predicting Progression in High-Grade Glioma after Proton and Carbon Ion Radiotherapy.
    Qiu X; Gao J; Yang J; Hu J; Hu W; Kong L; Lu JJ
    Front Oncol; 2020; 10():551420. PubMed ID: 33194609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine learning and radiomic phenotyping of lower grade gliomas: improving survival prediction.
    Choi YS; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Jain R; Lee SK
    Eur Radiol; 2020 Jul; 30(7):3834-3842. PubMed ID: 32162004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.
    Kim M; Jung SY; Park JE; Jo Y; Park SY; Nam SJ; Kim JH; Kim HS
    Eur Radiol; 2020 Apr; 30(4):2142-2151. PubMed ID: 31828414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of treatment strategy by using a machine learning model to predict survival time of patients with malignant glioma after radiotherapy.
    Mizutani T; Magome T; Igaki H; Haga A; Nawa K; Sekiya N; Nakagawa K
    J Radiat Res; 2019 Nov; 60(6):818-824. PubMed ID: 31665445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome Prediction for Patient with High-Grade Gliomas from Brain Functional and Structural Networks.
    Liu L; Zhang H; Rekik I; Chen X; Wang Q; Shen D
    Med Image Comput Comput Assist Interv; 2016 Oct; 9901():26-34. PubMed ID: 28649677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
    Cheng W; Li M; Jiang Y; Zhang C; Cai J; Wang K; Wu A
    J Neurosurg; 2016 Jul; 125(1):7-16. PubMed ID: 26544773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine learning reveals multimodal MRI patterns predictive of isocitrate dehydrogenase and 1p/19q status in diffuse low- and high-grade gliomas.
    Zhou H; Chang K; Bai HX; Xiao B; Su C; Bi WL; Zhang PJ; Senders JT; Vallières M; Kavouridis VK; Boaro A; Arnaout O; Yang L; Huang RY
    J Neurooncol; 2019 Apr; 142(2):299-307. PubMed ID: 30661193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast enhancement is a prognostic factor in IDH1/2 mutant, but not in wild-type WHO grade II/III glioma as confirmed by machine learning.
    Suchorska B; Schüller U; Biczok A; Lenski M; Albert NL; Giese A; Kreth FW; Ertl-Wagner B; Tonn JC; Ingrisch M
    Eur J Cancer; 2019 Jan; 107():15-27. PubMed ID: 30529899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving survival prediction of high-grade glioma via machine learning techniques based on MRI radiomic, genetic and clinical risk factors.
    Tan Y; Mu W; Wang XC; Yang GQ; Gillies RJ; Zhang H
    Eur J Radiol; 2019 Nov; 120():108609. PubMed ID: 31606714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing a machine learning based glioma grading system using multi-parametric MRI histogram and texture features.
    Zhang X; Yan LF; Hu YC; Li G; Yang Y; Han Y; Sun YZ; Liu ZC; Tian Q; Han ZY; Liu LD; Hu BQ; Qiu ZY; Wang W; Cui GB
    Oncotarget; 2017 Jul; 8(29):47816-47830. PubMed ID: 28599282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis prediction of extremity and trunk wall soft-tissue sarcomas treated with surgical resection with radiomic analysis based on random survival forest.
    Yang Y; Ma X; Wang Y; Ding X
    Updates Surg; 2022 Feb; 74(1):355-365. PubMed ID: 34003477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overall survival time prediction for high-grade glioma patients based on large-scale brain functional networks.
    Liu L; Zhang H; Wu J; Yu Z; Chen X; Rekik I; Wang Q; Lu J; Shen D
    Brain Imaging Behav; 2019 Oct; 13(5):1333-1351. PubMed ID: 30155788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and internal validation of machine learning models for personalized survival predictions in spinal cord glioma patients.
    Karabacak M; Schupper AJ; Carr MT; Bhimani AD; Steinberger J; Margetis K
    Spine J; 2024 Jun; 24(6):1065-1076. PubMed ID: 38365005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining MRI and Histologic Imaging Features for Predicting Overall Survival in Patients with Glioma.
    Rathore S; Chaddad A; Iftikhar MA; Bilello M; Abdulkadir A
    Radiol Imaging Cancer; 2021 Jul; 3(4):e200108. PubMed ID: 34296969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiomics-Based Machine Learning Classification for Glioma Grading Using Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging.
    Hashido T; Saito S; Ishida T
    J Comput Assist Tomogr; 2021 Jul-Aug 01; 45(4):606-613. PubMed ID: 34270479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Genetic Profiles and Prognosis of High-Grade Gliomas Using Quantitative and Qualitative MRI Features: A Focus on G3 Gliomas.
    Hong EK; Choi SH; Shin DJ; Jo SW; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH; Park SH; Won JK; Kim TM; Park CK; Kim IH; Lee ST
    Korean J Radiol; 2021 Feb; 22(2):233-242. PubMed ID: 32932560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics strategy for glioma grading using texture features from multiparametric MRI.
    Tian Q; Yan LF; Zhang X; Zhang X; Hu YC; Han Y; Liu ZC; Nan HY; Sun Q; Sun YZ; Yang Y; Yu Y; Zhang J; Hu B; Xiao G; Chen P; Tian S; Xu J; Wang W; Cui GB
    J Magn Reson Imaging; 2018 Dec; 48(6):1518-1528. PubMed ID: 29573085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine learning: a useful radiological adjunct in determination of a newly diagnosed glioma's grade and IDH status.
    De Looze C; Beausang A; Cryan J; Loftus T; Buckley PG; Farrell M; Looby S; Reilly R; Brett F; Kearney H
    J Neurooncol; 2018 Sep; 139(2):491-499. PubMed ID: 29770897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of
    Debus C; Waltenberger M; Floca R; Afshar-Oromieh A; Bougatf N; Adeberg S; Heiland S; Bendszus M; Wick W; Rieken S; Haberkorn U; Debus J; Knoll M; Abdollahi A
    Sci Rep; 2018 May; 8(1):7201. PubMed ID: 29740097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.